U.S. to buy Siga's IV drug worth $26 mln to fight monkeypox outbreak

Reuters/REUTERS

Siga Technologies Inc said on Tuesday the U.S. government has decided to procure its intravenous (IV) formulation

Leroy Leo, Reuters News

August 9, 2022

PHOTO

Siga Technologies Inc said on Tuesday the U.S. government has decided to procure its intravenous (IV) formulation of antiviral drug Tpoxx worth $26 million at a time when the country is fighting an outbreak of monkeypox cases. (Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)

Reuters

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.